Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Clinical

  • 1
    News

    Aspirin efficacious and safe for VTE prophylaxis in total hip and knee replacement

    July 23, 2021

    Is aspirin effective and safe for VTE prophylaxis in patients undergoing total hip and knee replacement?

  • 1
    News

    CDC panel updates info on rare side effect after J&J vaccine

    July 23, 2021

    To date, more than 12 million doses of the vaccine have been administered, making the rate of GBS 8.1 cases for every million doses administered.

  • Article

    Rising meth-related heart failure admissions a ‘crisis,’ costly for society

    July 23, 2021

    ‘They’re not going to die from it overnight, but it will damage the heart slowly,’ a researcher said. Meth-related HF admissions exploded in the western United States over a recent decade.

  • 1
    News

    PHM virtual conference promises practical pearls, plus Dr. Fauci

    July 23, 2021

    A “full spectrum” of offerings at the upcoming Pediatric Hospital Medicine 2021 virtual conference.

  • News

    Delta variant among the most infectious respiratory viruses, CDC says

    July 22, 2021

    CDC Director Rochelle Walensky, MD, called the COVID-19 Delta variant “one of the most infectious respiratory viruses we know of” and reported more cases and hospitalizations.

  • 1
    News

    Acid suppression therapy increases intestinal colonization of MDROs

    July 22, 2021

    Is acid suppression therapy associated with an increased risk of intestinal colonization with multidrug-resistant microorganisms (MDROs)?

  • News

    Sickle cell disease, trait may up risk for poor COVID outcomes

    July 21, 2021

    Even those who carry just one copy of the sickle cell gene – the carrier status for sickle cell disease – appeared to be at heightened risk.

  • 1
    News

    Statins again linked to lower COVID-19 mortality

    July 21, 2021

    Patients hospitalized for COVID-19 who had been taking statins had a substantially lower risk of death and severe outcomes than those who weren’t in a large observational study.

  • News

    ‘Dealing with a different beast’: Why Delta has doctors worried

    July 21, 2021

    “We are either going to get vaccinated and end the pandemic, or we’re going to accept death and a lot of it.”

  • 1
    News

    Empirical anti-MRSA therapy does not improve mortality in patients with pneumonia

    July 21, 2021

    Does empirical anti–methicillin-resistant Staphylococcus aureus (MRSA) therapy affect 30-day mortality in patients hospitalized with pneumonia, when compared with standard antibiotic regimens?

Previous1 … 48 49 50 51 52 … 402Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences